|
|
Sessions Include: |
-
Biomarkers and Surrogates
-
Tumor Targeting and Validation
-
Fully Human Monoclonal Antibodies
-
New Targets
-
Immunomodulators/Adjuvants
- Autologus Cell Technologies
|
|
Keynote Presentations: |
Misguiding Cues used by Viruses to Thwart Protective Immunity:
Lessons for Tumor Immunity
Ellis L. Reinherz MD, Professor of Medicine, Harvard Medical School; Director, Cancer Vaccine
Center and Chief, Laboratory of Immunobiology, Dana Farber Cancer Institute, USA
New Vaccine Technologies: A
Regulatory Perspective
Jon R. Daugherty, Ph.D., U.S. Public Health Service, Senior Regulatory
Review
Officer, Office of Vaccines Research and Review,
CBER/FDA
|
|
Featured
Speaker:
|
Adjuvanting DNA Vaccines
David B. Weiner, Ph.D., Chair, Gene Therapy and Vaccines Program, CAMB, Department of Pathology, University of Pennsylvania School of Medicine
|
|
For more information, please contact:
Margit Eder, Ph.D., Conference Director, Cambridge Healthtech Institute
Phone: 781-972-5478 E-mail: meder@healthtech.com
For exhibit and sponsorship information, please
contact:
Suzanne Carroll, Manager, Business Development
Phone: 781-972-5452 • E-mail: scarroll@healthtech.com
|
